Adar1 Capital Management, LLC Ascendis Pharma A/S Transaction History
Adar1 Capital Management, LLC
- $652 Billion
- Q2 2025
A detailed history of Adar1 Capital Management, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 1,402 shares of ASND stock, worth $281,759. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,402
Previous 1,402
-0.0%
Holding current value
$281,759
Previous $219 Million
10.74%
% of portfolio
0.04%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding ASND
# of Institutions
276Shares Held
60MCall Options Held
217KPut Options Held
73.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.07 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.1 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$1 Billion15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$890 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$855 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.2B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...